Increased expression of IDO associates with poor postoperative clinical outcome of patients with gastric adenocarcinoma
2016 · Scientific Reports · 94 citations
https://doi.org/10.1038/srep21319
Z
Zhenbin Shen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
58
Papers
1.2K
Citations
18
h-index
24
i10-index
Zhenbin Shen is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Gastric Cancer Management and Outcomes & Immune cells in cancer & Metastasis and carcinoma case studies. The author has an h-index of 18, co-authored 50 publications.
Papers by this author
worksA phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis
2014 · Cancer Chemotherapy and Pharmacology · 74 citations
https://doi.org/10.1007/s00280-014-2449-1
Targeting ZFP64/GAL-1 axis promotes therapeutic effect of nab-paclitaxel and reverses immunosuppressive microenvironment in gastric cancer
2022 · Journal of Experimental & Clinical Cancer Research · 47 citations
https://doi.org/10.1186/s13046-021-02224-x
The prognostic value of CXC-chemokine receptor 2 (CXCR2) in gastric cancer patients
2015 · BMC Cancer · 33 citations
https://doi.org/10.1186/s12885-015-1793-9
Decreased expression of Calpain-9 predicts unfavorable prognosis in patients with gastric cancer
2016 · Scientific Reports · 31 citations
https://doi.org/10.1038/srep29604
Additional file 1: Figure: S1. of The IGCA staging system is more accurate than AJCC7 system in stratifying survival of patients with gastric cancer in stage III
2017 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.c.3730999_d1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat